Literature DB >> 30133642

In vitro antifungal susceptibility of Candida speciesisolated from diabetic patients.

Mohammad Taghi Hedayati1,2, Mahin Tavakoli2,3, Fateme Zakavi4, Tahereh Shokohi1,2, Ramin Mofarrah5, Saham Ansari6, Mojtaba Taghizadeh Armaki7.   

Abstract

INTRODUCTION: This study aims to evaluate the antifungal susceptibility of different species of Candida isolated from diabetic patients against eight antifungal agents.
METHODS: Susceptibility testing of 111 clinical isolates of Candida species was performed against 8 antifungals using the M27-A3 protocol of the Clinical and Laboratory Standards Institute (CLSI).
RESULTS: Voriconazole, lanoconazole, and caspofungin showed the highest in vitro activity against all the isolates of C. albicans. Resistance against the tested antifungals was only observed in the C. albicans isolates.
CONCLUSIONS: Our finding revealed that resistance against amphotericin B, itraconazole, ketoconazole, posaconazole, and fluconazole can be observed in C. albicans.

Entities:  

Mesh:

Substances:

Year:  2018        PMID: 30133642     DOI: 10.1590/0037-8682-0332-2017

Source DB:  PubMed          Journal:  Rev Soc Bras Med Trop        ISSN: 0037-8682            Impact factor:   1.581


  2 in total

1.  The newly synthesized thiazole derivatives as potential antifungal compounds against Candida albicans.

Authors:  Anna Biernasiuk; Anna Berecka-Rycerz; Anna Gumieniczek; Maria Malm; Krzysztof Z Łączkowski; Jolanta Szymańska; Anna Malm
Journal:  Appl Microbiol Biotechnol       Date:  2021-08-19       Impact factor: 4.813

2.  High prevalence of itraconazole resistance among Candida parapsilosis isolated from Iran.

Authors:  Fozieh Hassanmoghadam; Tahereh Shokohi; Mohammad Taghi Hedayati; Narges Aslani; Iman Haghani; Mojtaba Nabili; Ensieh Lotfali; Amirhossein Davari; Maryam Moazeni
Journal:  Curr Med Mycol       Date:  2019-09
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.